Internal Jugular Venous Distensibility Index and Innominate Venous Flow Patterns As Predictors of Fluid Responsiveness

March 1, 2025 updated by: Dita Aditianingsih, Indonesia University

Internal Jugular Venous Distensibility Index and Innominate Venous Flow Patterns As Predictors of Response to Fluid Administration in Elective Surgery Patients

The measurement of internal jugular vein distensibility index corresponds to the measurement of stroke volume using trans-thoracic Doppler echocardiography in assessing the response to fluid administration in elective surgical patients.

Study Overview

Study Type

Observational

Enrollment (Actual)

79

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • DKI Jakarta
      • Jakarta Pusat, DKI Jakarta, Indonesia, 10430
        • Rumah Sakit Cipto Mangunkusumo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Adult patients aged 18-65 years undergoing elective surgery with general anesthesia at RSUPN dr. Cipto Mangunkusumo Jakarta.

Description

Inclusion Criteria:

  1. Utilizing intraoperative mechanical ventilation with a tidal volume of 8 ml/kg (PBW).
  2. ASA physical status 1-3.
  3. Mongoloid ethnicity.
  4. Willing to participate in the research and sign the informed consent.

Exclusion Criteria:

  1. Patients with symptoms and signs of fluid overload, such as pulmonary edema, pleural effusion, ascites, and peripheral edema.
  2. Patients with chronic or acute kidney dysfunction, renal replacement therapy history, and/or oliguria (urine output <0.5 ml/kg/hour).
  3. Patients with cardiovascular diseases, including heart failure, cardiac arrhythmias, moderate-to-severe valvular abnormalities, a history of angina/myocardial infarction, pulmonary hypertension, and peripheral artery disease.
  4. Patients with anatomical abnormalities in the neck and chest region that make it impractical to perform jugular vein ultrasound and transthoracic echocardiography.
  5. Jugular vein thrombosis.
  6. Superior vena cava syndrome.
  7. Placement of jugular vein catheter.
  8. Body mass index (BMI) greater than 30.0 kg/m2.
  9. Patients with contraindications to the use of muscle relaxants.
  10. Patients with lung hyperinflation and pleural effusion.

Drop out criteria:

  1. Patients who wish to withdraw from the study.
  2. Post-anesthesia induction complications and emergencies.
  3. Transthoracic echocardiography provides a less representative image due to difficult acoustic window.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
IJV distensibility index correlation to fluid responsiveness
Time Frame: 1 day
Correlation between IJV distensibility index and fluid responsiveness defined as increase of stroke volume more than 10% after fluid challenge
1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comparison of IJV distensibility index in fluid responders and non-fluid responders.
Time Frame: 1 day
1 day
Detection of sensitivity, specificity, positive predictive value, negative predictive value, and best cut off value of IJV distensibility index to predict fluid responsiveness
Time Frame: 1 day
By ROC curve and Youden index
1 day
Correlation of IJV distensibility index and stroke volume
Time Frame: 1 day
1 day
Innominate vein flow velocity correlation to fluid responsiveness
Time Frame: 1 day
Correlation between Innominate vein flow velocity and fluid responsiveness defined as increase of stroke volume more than 10% after fluid challenge
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Dita Aditianingsih, Indonesia University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Actual)

July 31, 2023

Study Completion (Actual)

September 5, 2023

Study Registration Dates

First Submitted

June 26, 2023

First Submitted That Met QC Criteria

June 26, 2023

First Posted (Actual)

July 5, 2023

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 1, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • IndonesiaUAnes044

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hemodynamic Monitoring

Clinical Trials on Ultrasonography of Internal Jugular Vein

Subscribe